炎症性肠病内镜下异型增生监测更新
随着炎症性肠病内科治疗进展,多数患者预期寿命长且无需全结肠切除,但病程延长使异型增生致结直肠癌风险增加。内镜技术进步使多数既往不可见异型增生变为可见,新工具助避免结肠切除但需持续结肠监测。随机活检必要性、首选内镜成像技术及异型增生切除后监测间隔等方面数据有限或矛盾,指南应用与先进成像技术可及性及培训存在显著差异。本文叙述性综述高危患者、当前监测结肠镜指南、影响最佳黏膜可视化因素、增强成像技术、标准化报告术语、异型增生的内镜管理、结肠切除指征及未来潜在技术。
要点
- 随着炎症性肠病内科治疗进展,多数患者预期寿命长且无需全结肠切除
- 病程延长使异型增生致结直肠癌风险增加,先进成像技术使多数既往不可见异型增生变为可见
- 随机活检必要性、首选内镜成像技术及异型增生切除后监测间隔等方面数据有限或矛盾,推荐不一致
核心结论
- 随着炎症性肠病内科治疗进展,多数患者预期寿命长且无需全结肠切除,但病程延长使异型增生致结直肠癌风险增加。
- 先进成像技术使多数既往不可见异型增生变为可见,新工具助避免结肠切除但需持续结肠监测。
- 随机活检必要性、首选内镜成像技术及异型增生切除后监测间隔等方面数据有限或矛盾,推荐不一致。
研究设计与样本
- 本文为叙述性综述,未报告系统检索范围与样本量。
主要发现
- 过去十年已发表多个共识与指南文件,推荐优化异型增生病变的早期检测与管理。
- 内镜技术近年大幅进步,先进成像技术使黏膜检查更清晰详细,多数既往不可见异型增生变为可见。
- 促进可见病变内镜切除的新工具使患者得以避免结肠切除,但需继续结肠监测。
- 随机活检必要性、首选内镜成像技术及异型增生切除后监测间隔等方面数据有限或矛盾,推荐不一致。
- 指南在日常实践中的应用及先进成像技术的可及性与培训仍存在显著差异。
关键数值与推荐
- 原文未报告具体推荐条款与数值。
临床怎么用
- 原文未据此给出推荐。
局限性
- 随机活检必要性、首选内镜成像技术及异型增生切除后监测间隔等方面数据有限或矛盾,推荐不一致。
- 指南在日常实践中的应用及先进成像技术的可及性与培训存在显著差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
As medical management of inflammatory bowel disease makes great advances, most patients with inflammatory bowel disease will have long life expectancies without need for total colectomy. With prolonged disease duration, however, there is increased risk of dysplasia leading to colorectal cancer. Multiple consensus and guideline documents have been published over the last decade with recommendations to optimize early detection and management of dysplastic lesions. Endoscopic technology has improved tremendously, even over the past few years. Previously invisible dysplasia has become visible in most cases with advanced imaging technologies that now allow for much clearer and more detailed mucosal inspection. New tools to facilitate endoscopic resection of visible lesions have also enabled patients to avoid colectomy, with resulting need to continue colon surveillance. There are limited or conflicting data leading to inconsistent recommendations regarding the need for random biopsies, the preferred endoscopic imaging technique, and surveillance intervals after resection of dysplasia. Similarly, there remains significant variability in the application of guidelines into daily practice and availability of and training with advanced imaging technologies. Here, we present a narrative review of which patients are at highest risk for dysplasia, the current guidelines on surveillance colonoscopy, factors affecting optimal mucosal visualization, enhanced imaging techniques, standardized reporting terminologies for surveillance colonoscopy, endoscopic management of dysplasia, indications for colectomy, and briefly on future potential technologies to assist in dysplasia detection.
引用
- Coelho-Prabhu N, Lewis JD. Update on Endoscopic Dysplasia Surveillance in Inflammatory Bowel Disease. Am J Gastroenterol. 2023. PMID: 37543741. doi:10.14309/ajg.0000000000002460
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。